doc. MUDr. Daniela Žáčková, Ph.D.

2010

• A guide to cytogenetic and FISH monitiring

  ŽÁČKOVÁ D

  Appeared in Conference without Proceedings

  Year: 2010, type: Appeared in Conference without Proceedings

• Adverse events of TKIs-their management and their role in choosing second line therapy.

  ŽÁČKOVÁ Daniela

  Appeared in Conference without Proceedings

  Year: 2010, type: Appeared in Conference without Proceedings

• Analýza mutací BCR-ABL u CML pacientů rezistentních k imatinibu umožňuje poskytnout „terapii šitou na míru“

  ŠŤASTNÝ M. MACHOVÁ POLÁKOVÁ K. KLAMOVÁ H. ŽÁČKOVÁ Daniela VOGLOVÁ J. KARAS M. MORAVCOVÁ J. FABER E.

  Article in Periodical

  Transfuze a hematologie dnes, year: 2010, volume: 16, edition: 1

• Constant BCR-ABL transcript level >or=0.1% (IS) in patients with CML responding to imatinib with complete cytogenetic remission may indicate mutation analysis.

  MACHOVÁ POLÁKOVÁ Kateřina POLÍVKOVÁ Václava RULCOVÁ Jana KLAMOVÁ Hana JURČEK Tomáš DVOŘÁKOVÁ Dana ŽÁČKOVÁ Daniela POSPÍŠIL Zdeněk MAYER Jiří MORAVCOVÁ Jana

  Article in Periodical

  Experimental hematology, year: 2010, volume: 38, edition: 1

• Dasatinib in imatinib-resistant or -intolerant CML patients: data from the clinical practice of 6 hematological centers in the Czech Republic

  KLAMOVA H. FABER E. ŽÁČKOVÁ Daniela MARKOVA M. VOGLOVA J. CMUNT E. NOVAKOVA L. MACHOVA-POLAKOVA K. MORAVCOVA J. DVOŘÁKOVÁ Dana MICHALOVA K. BREZINOVA J. OLTOVÁ Alexandra JAROŠOVÁ Marie CETKOVSKÝ Petr INDRAK K. MAYER Jiří

  Article in Periodical

  Neoplasma, year: 2010, volume: 57, edition: 4, DOI

• Detection of an aberrant form of E13A2 BCR-ABL transcript causing failure of molecular diagnostics in patient with chronic myeloid leukemia (CML)

  JURČEK Tomáš RÁZGA Filip JEŽÍŠKOVÁ Ivana ŽÁČKOVÁ D. MAYER Jiří DVOŘÁKOVÁ Dana

  Conference abstract

  Year: 2010, type: Conference abstract

• EUROPEAN SUB-REGISTRY OF CHRONIC MYELOID LEUKEMIA (CML) PATIENTS (PTS) IN FAILURE AFTER IMATINIB THERAPY (IFP): RATIONALE, STUDY DESIGN AND CURRENT STATUS. A STUDY FROM THE EUROPEAN LEUKEMIANET (ELN)

  GUILHOT J TARTARIN F HOCHHAUS A SAUSSELE S NICOLINI F ROSTI G STEEGMAN JL SACHA T COUTRE P Le NAGLER A ABRUZZESE E HEIM D CLARK R STENTOFT J FABER E PORKKA K CERVANTES F HÖGLUND M O BRIEN S THALER J TURKINA A OSSENKOPPELE G ŽÁČKOVÁ Daniela KLAMOVÁ H GAMBACORTI C PFIRRMANN M HASFORD J HELMANN R

  Conference abstract

  Year: 2010, type: Conference abstract

• Failure of molecular diagnostics in chronic myeloid leukemia - an aberrant form of e13a2 BCR-ABL transcript causing false-negative results by standard PCR.

  JURČEK Tomáš RÁZGA Filip JEŽÍŠKOVÁ Ivana DVOŘÁKOVÁ Dana ŽÁČKOVÁ Daniela TOMÁŠIKOVÁ Lenka OLTOVÁ Alexandra MAYER Jiří

  Article in Periodical

  LEUKEMIA & LYMPHOMA, year: 2010, volume: 51, edition: 3

• Frekvence mutací v BCR-ABL kinázové doméně u pacientů s chronickou myeloidní leukémií (CML) léčených tyrozinkinázovými inhibitory - zkušenosti IHOK FN Brno

  JURČEK Tomáš RÁZGA Filip ŽÁČKOVÁ Daniela DOBEŠOVÁ Blanka RÁČIL Zdeněk JEŽÍŠKOVÁ Ivana DVOŘÁKOVÁ Dana MAYER Jiří

  Conference abstract

  Year: 2010, type: Conference abstract

• Chronická myeloidní leukemie v éře tyrozinkinázových inhibitorů

  ŽÁČKOVÁ Daniela

  Appeared in Conference without Proceedings

  Year: 2010, type: Appeared in Conference without Proceedings